Tetracyclic antidepressant: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
'''Tetracyclic antidepressants''' ('''TeCAs''') are a class of [[antidepressants]] that were first introduced in the 1970s. They are named after their chemical structure, which contains four rings of atoms, and are closely related to the [[tricyclic antidepressants]] (TCAs), which contain three rings of atoms.
{{Short description|Overview of tetracyclic antidepressants}}
{{Drugbox}}


== History ==
==Tetracyclic Antidepressants==
[[File:Mirtazapine.svg|thumb|right|Chemical structure of Mirtazapine, a tetracyclic antidepressant]]
Tetracyclic antidepressants (TeCAs) are a class of [[antidepressant]] drugs that are chemically distinct from the more common [[tricyclic antidepressants]] (TCAs). They are named for their four-ring chemical structure. TeCAs are primarily used in the treatment of [[major depressive disorder]] and other mood disorders.


The first TeCA, [[maprotiline]], was introduced in the 1970s. It was followed by [[mianserin]] in 1977 and [[amoxapine]] in 1992. These medications were developed as a result of research aimed at finding new and more effective treatments for [[depression]].
==Mechanism of Action==
TeCAs work by modulating the levels of neurotransmitters in the brain, particularly [[serotonin]] and [[norepinephrine]]. They are known to block certain receptors, such as the [[alpha-2 adrenergic receptor]], which leads to an increase in the release of norepinephrine and serotonin. This action is thought to contribute to their antidepressant effects.


== Mechanism of action ==
==Common Tetracyclic Antidepressants==
One of the most well-known tetracyclic antidepressants is [[mirtazapine]]. Mirtazapine is often used for its sedative properties and is sometimes prescribed to patients who have difficulty sleeping. It is also known for having a lower incidence of sexual side effects compared to other antidepressants.


TeCAs work by inhibiting the reuptake of certain [[neurotransmitters]] in the brain, including [[norepinephrine]], [[serotonin]], and, to a lesser extent, [[dopamine]]. This increases the levels of these neurotransmitters in the brain, which can help to alleviate the symptoms of depression.
==Side Effects==
TeCAs can cause a range of side effects, which may include [[weight gain]], [[sedation]], and [[dry mouth]]. Some patients may experience dizziness or [[orthostatic hypotension]]. It is important for patients to discuss potential side effects with their healthcare provider.


== Uses ==
==Comparison with Other Antidepressants==
TeCAs are less commonly prescribed than [[selective serotonin reuptake inhibitors]] (SSRIs) and [[serotonin-norepinephrine reuptake inhibitors]] (SNRIs) due to their side effect profile. However, they may be beneficial for patients who do not respond to other treatments or who have specific symptoms that TeCAs can address.


TeCAs are primarily used to treat [[major depressive disorder]], but they can also be used to treat other conditions, such as [[anxiety disorders]], [[obsessive-compulsive disorder]] (OCD), and certain types of [[chronic pain]].
==Related pages==
 
== Side effects ==
 
Like all medications, TeCAs can cause side effects. These can include [[drowsiness]], [[dizziness]], [[dry mouth]], [[constipation]], [[blurred vision]], and [[weight gain]]. In rare cases, they can also cause more serious side effects, such as [[suicidal thoughts]] or behaviors.
 
== See also ==
 
* [[Antidepressant]]
* [[Tricyclic antidepressant]]
* [[Tricyclic antidepressant]]
* [[Selective serotonin reuptake inhibitor]]
* [[Selective serotonin reuptake inhibitor]]
* [[Serotonin-norepinephrine reuptake inhibitor]]
* [[Serotonin-norepinephrine reuptake inhibitor]]
 
* [[Major depressive disorder]]
== References ==
 
<references />


[[Category:Antidepressants]]
[[Category:Antidepressants]]
[[Category:Psychiatric drugs]]
[[Category:Tetracyclic antidepressants]]
[[Category:Medicine]]
 
{{stub}}

Latest revision as of 05:53, 16 February 2025

Overview of tetracyclic antidepressants


Tetracyclic antidepressant
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Tetracyclic Antidepressants[edit]

Chemical structure of Mirtazapine, a tetracyclic antidepressant

Tetracyclic antidepressants (TeCAs) are a class of antidepressant drugs that are chemically distinct from the more common tricyclic antidepressants (TCAs). They are named for their four-ring chemical structure. TeCAs are primarily used in the treatment of major depressive disorder and other mood disorders.

Mechanism of Action[edit]

TeCAs work by modulating the levels of neurotransmitters in the brain, particularly serotonin and norepinephrine. They are known to block certain receptors, such as the alpha-2 adrenergic receptor, which leads to an increase in the release of norepinephrine and serotonin. This action is thought to contribute to their antidepressant effects.

Common Tetracyclic Antidepressants[edit]

One of the most well-known tetracyclic antidepressants is mirtazapine. Mirtazapine is often used for its sedative properties and is sometimes prescribed to patients who have difficulty sleeping. It is also known for having a lower incidence of sexual side effects compared to other antidepressants.

Side Effects[edit]

TeCAs can cause a range of side effects, which may include weight gain, sedation, and dry mouth. Some patients may experience dizziness or orthostatic hypotension. It is important for patients to discuss potential side effects with their healthcare provider.

Comparison with Other Antidepressants[edit]

TeCAs are less commonly prescribed than selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) due to their side effect profile. However, they may be beneficial for patients who do not respond to other treatments or who have specific symptoms that TeCAs can address.

Related pages[edit]